Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

172 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Ferrara JL, Abhyankar S, Gilliland DG. Ferrara JL, et al. Among authors: abhyankar s. Transplant Proc. 1993 Feb;25(1 Pt 2):1216-7. Transplant Proc. 1993. PMID: 8442093 No abstract available.
Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.
Sakamoto H, Michaelson J, Jones WK, Bhan AK, Abhyankar S, Silverstein M, Golan DE, Burakoff SJ, Ferrara JL. Sakamoto H, et al. Among authors: abhyankar s. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10890-4. doi: 10.1073/pnas.88.23.10890. Proc Natl Acad Sci U S A. 1991. PMID: 1835792 Free PMC article.
Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors.
Lamb LS Jr, Gee AP, Henslee-Downey PJ, Geier SS, Hazlett L, Pati AR, Godder K, Abhyankar SA, Turner MW, Lee C, Harris WG, Parrish RS. Lamb LS Jr, et al. Among authors: abhyankar sa. Bone Marrow Transplant. 1998 Mar;21(5):461-71. doi: 10.1038/sj.bmt.1701110. Bone Marrow Transplant. 1998. PMID: 9535038 Clinical Trial.
Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.
Deeg HJ, Blazar BR, Bolwell BJ, Long GD, Schuening F, Cunningham J, Rifkin RM, Abhyankar S, Briggs AD, Burt R, Lipani J, Roskos LK, White JM, Havrilla N, Schwab G, Heslop HE. Deeg HJ, et al. Among authors: abhyankar s. Blood. 2001 Oct 1;98(7):2052-8. doi: 10.1182/blood.v98.7.2052. Blood. 2001. PMID: 11567989 Clinical Trial.
Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
Godder KT, Henslee-Downey PJ, Mehta J, Park BS, Chiang KY, Abhyankar S, Lamb LS. Godder KT, et al. Among authors: abhyankar s. Bone Marrow Transplant. 2007 Jun;39(12):751-7. doi: 10.1038/sj.bmt.1705650. Epub 2007 Apr 23. Bone Marrow Transplant. 2007. PMID: 17450185 Clinical Trial.
Partially mismatched related donor transplants as salvage therapy for patients with refractory leukemia who relapse post-BMT.
Godder K, Pati A, Abhyankar S, Gee AP, Parrish R, Lee C, Henslee-Downey PJ. Godder K, et al. Among authors: abhyankar s. Bone Marrow Transplant. 1996 Jan;17(1):49-53. Bone Marrow Transplant. 1996. PMID: 8673054
Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease.
Lamb LS Jr, Abhyankar SA, Hazlett L, O'Neal W, Folk RS, Vogt S, Parrish RS, Bridges K, Henslee-Downey PJ, Gee AP. Lamb LS Jr, et al. Among authors: abhyankar sa. Cytometry. 1999 Oct 15;38(5):238-43. doi: 10.1002/(sici)1097-0320(19991015)38:5<238::aid-cyto6>3.0.co;2-o. Cytometry. 1999. PMID: 10516610
Evaluation of the half-life of intravenous human cytomegalovirus immune globulin in patients receiving partially mismatched related donor bone marrow transplantation.
DeRienzo SY, Chiang KY, O'Neal WM, Godder K, Abhyankar S, Christiansen NP, Bridges KD, Henslee-Downey PJ. DeRienzo SY, et al. Among authors: abhyankar s. Pharmacotherapy. 2000 Oct;20(10):1175-8. doi: 10.1592/phco.20.15.1175.34592. Pharmacotherapy. 2000. PMID: 11034040
CONCLUSION: We believe this is the first report of CytoGam's half-life in allogeneic BMT. The information may prove vital in a future study in which the agent's potential beneficial effects can be maximized....
CONCLUSION: We believe this is the first report of CytoGam's half-life in allogeneic BMT. The information may prove vital in a future …
172 results
Jump to page
Feedback